Michelle Obama’s weight loss sparks discussions about Ozempic

Michelle Obama's recent weight loss has led to speculation regarding potential use of Ozempic or similar medications.

November 26, 2025

Benjamin Hart

Michelle Obama’s Transformation

Former First Lady Michelle Obama has recently drawn attention for her noticeably slim figure, leading many to speculate that she may be among the growing number of Americans using Ozempic or similar GLP-1 weight loss medications.

In a stunning photo shoot with renowned photographer Annie Leibovitz, the 61-year-old mother of two showcased her new look in skinny jeans, revealing toned abs and a significantly reduced waistline. Observers noted that her face appeared somewhat gaunt, which some interpret as a sign of rapid weight loss potentially linked to GLP-1 drugs.

While speculation surrounds Mrs. Obama’s weight loss, it coincides with a significant rise in prescriptions for GLP-1 medications for non-medical purposes—meaning individuals are seeking these drugs primarily for cosmetic reasons rather than underlying health issues like Type 2 diabetes.

A recent study published in the American Journal of Managed Care reported that the number of people prescribed these medications without obesity or diabetes-related conditions surged from fewer than 7,600 in 2018 to nearly 108,000 by 2023.

A variety of Hollywood figures have openly discussed their experiences with these medications. Some celebrities, including Oprah Winfrey and Kathy Bates, have acknowledged using them after experiencing significant weight gain. Others maintain silence on their methods despite appearing notably thin.

The mechanism behind these drugs involves slowing digestion and reducing appetite while also enhancing insulin function. Initially developed to assist Type 2 diabetes patients in managing blood glucose levels, they have gained traction among those looking to lose weight.

Despite her dramatic transformation, Mrs. Obama has not publicly commented on whether she is using any medication for weight loss. Dr. Alexandra Sowa, author of “The Ozempic Revolution,” expressed uncertainty about Mrs. Obama’s use but emphasized that if she were taking such medication, it could be for various reasons.

“We need to be cautious about celebrities who appear excessively thin,” Dr. Sowa remarked. “Being transparent about medication use could benefit many.”

The high cost of Ozempic—ranging from $350 to $500 monthly without insurance—limits access for many who could benefit from its effects. According to the National Institutes of Health, over 42% of American adults are classified as obese or severely obese.

The former First Lady has been candid about her struggles with weight throughout her life. In her memoir released in 2018, she described herself as a “chubby” child and a “decidedly un-skinny teenager,” noting how motherhood and menopause contributed to her fluctuating weight.

“I never used to weigh myself… but during menopause, you experience this gradual change that can catch you off guard,” she shared in an interview with People Magazine last year.

Dressed casually in jeans and suede boots during the Leibovitz shoot, Mrs. Obama shared glimpses on Instagram while announcing that one image would feature in Leibovitz’s upcoming photo book titled “Women.” She expressed appreciation for how photography can convey deeper messages beyond mere moments captured in time.

Mrs. Obama’s latest book titled “The Look,” released on November 4th, reflects on her style evolution during and after her time at the White House while highlighting how fashion has influenced her confidence.
Additionally, she co-hosts a podcast with her brother Craig Robinson.

The conversation around Mrs. Obama’s appearance intensified months ago when she posted a video dancing alongside Beyoncé’s mother during an episode of her podcast; viewers noted how slender she looked while moving energetically in loose-fitting attire.

Edited by:

Benjamin Hart

Photo of author
I focus on national security, defense policy, and military affairs, prioritizing accuracy and sober analysis. My work aims to clarify what matters beneath headlines and rhetoric.

Leave a Comment